Association of brachial-ankle pulse wave velocity with cardiovascular risk factors in systemic lupus erythematosus

Lupus

Volumn 14, Issue 11, 2005, Pages 878-883

  Tso, Tim K ^a   Huang, W N ^b,c   Huang, H Y ^a   Chang, C K ^d  

^a SHIH CHIEN UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY OF SPORT   (Taiwan)

Author keywords

Arterial stiffness; Atherosclerosis; Brachial ankle pulse wave velocity; Homocysteine; Systemic lupus erythematosus

Indexed keywords

HOMOCYSTEINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; REGRESSION ANALYSIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE;

ADULT; ANKLE; ARTERIOSCLEROSIS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BRACHIAL ARTERY; FEMALE; HOMOCYSTEINE; HUMANS; LIPIDS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PULSATILE FLOW; RISK FACTORS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 28444483563     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2234oa     Document Type: Article

References (49)

1. Steinberg AD, Klinman DM. Pathogenesis of systemic lupus erythematosus. Rheum Dis Clin N Am 1988; 14: 25-41.
2. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus: results from a single center. I. Causes of death. J Rheumatol 1995; 22: 1259-1264.
3. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 338-346.
4. Laurent S, Boutouyrie P, Asmar R et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
5. Brodszki J, Bengtsson C, Lanne T, Nived O, Sturfelt G, Marsal K. Abnormal mechanical properties of larger arteries in postmenopausal women with systemic lupus erythematosus. Lupus 2004; 13: 917-923.
6. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 2001; 21: 2046-2050.
7. Toto-Moukouo JJ, Achimastos A, Asmar RG, Hugues CJ, Safar ME. Pulse wave velocity in patients with obesity and hypertension. Am Heart J 1986; 112: 136-140.
8. Muramatsu J, Kobayashi A, Hasegawa N, Yokouchi S. Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin. Atherosclerosis 1997; 130: 179-182.
9. Airaksinen KE, Salmela PI, Linnaluoto MK, Ikaheimo MJ, Ahola K, Ryhanen LJ. Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovasc Res 1993; 27: 942-945.
10. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-1117.
11. Yamashina A, Tomiyama H, Takeda K et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
12. Aso K, Miyata M, Kubo T et al. Brachial-ankle pulse wave velocity is useful for evaluation of complications in type 2 diabetic patients. Hypertens Res 2003; 26: 807-813.
13. Yokoyama H, Hirasawa K, Aoki T, Ishiyama M, Koyama K. Brachial-ankle pulse wave velocity measured automatically by oscillometric method is elevated in diabetic patients with incipient nephropathy. Diabet Med 2003; 20: 942-945.
14. Choi KM, Lee KW, Seo JA et al. Relationship between brachial-ankle pulse wave velocity and cardiovascular risk factors of the metabolic syndrome. Diabetes Res Clin Pract 2004; 66: 57-61.
15. Ohnishi H, Saitoh S, Takagi S et al. Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose: The Tanno and Sobetsu Study. Diabetes Care 2003; 26: 437-440.
16. Munakata M, Ito N, Nunokawa T, Yoshinaga K. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003; 16: 653-657.
17. Imanishi R, Seto S, Toda G et al. High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertens Res 2004; 27: 71-78.
18. Selzer F, Sutton-Tyrrell K, Fitzgerald S, Tracy R, Kuller L, Manzi S. Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001; 37: 1075-1082.
19. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
20. Yamashina A, Tomiyama H, Arai T et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615-622.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
22. Oteiza PI, Olin KL, Fraga CG, Keen CL. Zinc deficiency causes oxidative damage to proteins, lipids and DNA in rat testes. J Nutr 1995; 125: 823-829.
23. Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
24. Chang DM, Lan JL, Lin HY, Luo SF. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus. Arthritis Rheum 2002; 46: 2924-2927.
25. Tso TK, Huang HY, Chang CK, Liao YJ, Huang WN. Clinical evaluation of insulin resistance and β-cell function by the homeostasis model assessment in patients with systemic lupus erythematosus. Clin Rheumatol 2004; 23: 416-420.
26. Sacks D, Bakal C, Beatty P et al. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease. J Vase Interv Radiol 2002; 13: 353.
27. Theodoridou A, Bento L, D'Cruz DP, Khamashta MA, Hughes GRV. Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study. Ann Rheum Dis 2003; 62: 1199-1203.
28. Newman AB, Siscovick DS, Manolio TA et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993; 88: 837-845.
29. van Popele NM, Grobbee DE, Bots ML et al. Association between arterial stiffness and atherosclerosis: The Rotterdam Study. Stroke 2001; 32: 454-460.
30. Tomiyama H, Yamashina A, Arai T et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12517 subjects. Atherosclerosis 2003; 166: 303-309.
31. Manzi S, Meilahn EN, Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997; 145: 408-415.
32. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992; 93: 513-519.
33. Roman MJ, Shanker B, Davis A et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399-2406.
34. Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 1993; 71: 26B-31B.
35. Tso TK, Huang WN, Huang HY, Liao YJ. Effect of anticardiolipin antibody on lipoprotein oxidation and antioxidant enzyme activities in normalipidaemic patients with systemic lupus erythematosus. Ann Rheum Dis 2004; 63 (Suppl I): 218 (abstract THU0368).
36. Tso TK, Huang WN, Huang HY, Liao YJ. Oxidative status and antioxidant enzyme activities in patients with systemic lupus erythematosus. Ann Rheum Dis 2004; 63 (Suppl I): 218 (abstract THU0369).
37. Clarke R, Daly L, Robinson K et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155.
38. Ueland PM, Refsum H, Beresford SAA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000; 72: 324-332.
39. Welch GN, Loscalzo JN. Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042-1050.
40. Hsu TS, Hsu LA, Chang CJ et al. Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study. Thromb Res 2001; 102: 387-395.
41. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease, probable benefits of increasing folic acid intakes. J Am Med Assoc 1995; 274: 1049-1057.
42. den Heijer M, Koster T, Blom HJ et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-762.
43. Refai TMK, Al-Salem IH, Nkansa-Dwamena D, Al-Salem MH. Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients. Clin Rheumatol 2002; 21: 457-461.
44. Petri M, Roubenoff R, Dallal GE et al. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996; 348: 1120-1124.
45. Fijnheer R, Roest M, Haas FJ et al. Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study. J Rheumatol 1998; 25: 1737-1742.
46. Huang WN, Tso TK, Huang HY, Liao YJ. Association of homocysteine with PWV in patients with systemic lupus erythematosus. Ann Rheum Dis 2004; 63 (Suppl I): 218 (abstract THU0370).
47. Hossain GS, van Thienen JV, Werstuck GH et al. TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the development of atherosclerosis in hyperhomocysteinemia. J Biol Chem 2003; 278: 30317-30327.
48. Zhang C, Cai Y, Adachi MT et al. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 2001; 276: 35867-35874.
49. Buemi M, Marino D, Di Pasquale G et al. Effects of homocysteine on proliferation, necrosis and apoptosis of vascular smooth muscle cells in culture and influence of folic acid. Thromb Res 2001; 104:207-213.